TBLU yields 3.33% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, TBLU + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TBLU + PFE for your $10,000?
TBLU offers exposure to developed-market all-cap water companies. The fund selects firms that derive at least 40% of gross revenues from either water infrastructure or water equipment and/or services. Water infrastructure companies are those that provide public water distribution, engineering, construction or consulting. Water equipment companies are those who provide water pipes, valves, pumps or water efficiency products such as filtration, treatment, and testing of water. Service companies provide technologies that facilitate management of water distribution, usage, treatment, and irrigation. The resulting portfolio includes a few dozen names, heavily weighted towards the US. Prior to June 5, 2018, the fund tracked the Tortoise Water Index, providing exposure to water companies in North America. Prior to the merger with Ecofin on Aug. 21, 2020, the fund name was Tortoise Global Water ESG Fund and traded under the ticker: TBLU. After the merger, the fund name changed to Ecofin Global Water ESG Fund and traded under the ticker: EBLU. On September 17, 2024, the fund name and ticker reverted to Tortoise Global Water ESG Fund and TBLU, respectively.
Full TBLU Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.